Robotic lobectomy for non–small cell lung cancer (NSCLC): Long-term oncologic results

Park, Bernard J.; Melfi, Franca; Mussi, Alfredo; Maisonneuve, Patrick; Spaggiari, Lorenzo; Silva, Ruy Kuenzer Caetano Da; Veronesi, Giulia

doi:10.1016/j.jtcvs.2011.10.055

Cited by 256 publications

(192 citation statements)

References 18 publications

Supporting

Mentioning

176

Contrasting

Unclassified

Order By: Relevance

“…The robotic approach involves articulated robotic arms together with a mini-thoracotomy. Large series of robotic lobectomy for early-stage lung cancer have now been reported and show excellent long-term oncological results [15,76]. Perioperative mortality is very low and complication rates similar to those expected with VATS lobectomy [15,76].…”

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 91%

“…Large series of robotic lobectomy for early-stage lung cancer have now been reported and show excellent long-term oncological results [15,76]. Perioperative mortality is very low and complication rates similar to those expected with VATS lobectomy [15,76]. PARK and FLORES [77] have reported that the cost of robotic lobectomy is still more than the cost of VATS lobectomy, but less than the cost of open lobectomy.…”

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 97%

“…PARK and FLORES [77] have reported that the cost of robotic lobectomy is still more than the cost of VATS lobectomy, but less than the cost of open lobectomy. In addition, the mean operating room time for a robotic lobectomy is still ,4 h, although decreasing with experience, at most institutions [15,76]. Considering the initial investment (robot) and the cost of disposables, this technique may be difficult to transpose to units with limited resources and set surgical volume targets.…”

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 99%

“…New techniques, such as radiofrequency ablation (RFA) or stereotactic body radiation therapy (SBRT), are now offered as an alternative to surgery in patients unfit for lung resection [5,14]. More recently, robotic approaches have been proposed in order to reduce the operative trauma, facilitate the surgical procedure and reduce the length of hospital stay [15]. All these techniques have yet to be validated and are currently being compared to conventional surgery in prospective randomised trials [5,16].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Surgery for nonsmall cell lung cancer

Lang-Lazdunski

2013

Eur Respir Rev

View full text Add to dashboard Cite

Surgery remains the best curative option in patients with early stage lung cancer (stage I and II). Developments in minimally invasive techniques now allow surgeons to perform lung resections on elderly patients, patients with poor pulmonary function or significant cardiopulmonary comorbidities. New techniques, such as stereotactic radiotherapy and ablative procedures, are being evaluated in early-stage lung cancer and may represent an alternative to surgery in patients unfit for lung resection. Perioperative mortality rates have dropped significantly at most institutions in the past two decades and complications are managed more efficiently. Progress in imaging and staging techniques have helped cut futile thoracotomy rates and offer patients the most adequate treatment options. Large randomised trials have helped clarify the role of neoadjuvant, induction and adjuvant chemotherapy, as well as radiotherapy. Surgery remains an essential step in the multimodality therapy of selected patients with advanced-stage lung cancer (stage III and IV). Interventional and endoscopic techniques have reduced the role of surgery in the diagnosis and staging of nonsmall cell lung cancer, but surgery remains an important tool in the palliation of advanced-stage lung cancer. Large national/international surgical databases have been developed and predictive risk-models for surgical mortality/morbidity published by learned surgical societies. Nonetheless, lung cancer overall survival rates remain deceptively low and it is hoped that early detection/screening, better understanding of tumour biology and development of biomarkers, and development of efficient targeted therapies will help improve the prognosis of lung cancer patients in the next decade. @ERSpublications Despite progress in surgical techniques, radiotherapy techniques and targeted therapy, lung cancer prognosis remains poor

show abstract

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 91%

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 97%

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Surgery for nonsmall cell lung cancer

Lang-Lazdunski

2013

Eur Respir Rev

View full text Add to dashboard Cite

show abstract

“…Besides offering obvious technical advantages, such as 3D high-definition vision and dedicated endo-wristed instruments, there is increasing evidence that this technique is associated with reductions in mortality, length of hospital stay and overall complication rates when compared with both open and video-assisted thoracic surgery (VATS) [1]. Furthermore, in the setting of non-small-cell lung cancer, long-term oncological results have been shown to be at least equal to open surgery and VATS [2]. Nevertheless, with the introduction of this new technology, as already experienced in VATS, a shift in proceduralrelated problems and challenges can be expected.…”

Section: Introductionmentioning

confidence: 99%

Robotic lobectomy: tips, pitfalls and troubleshooting

Kocher

Schmid

Melfi

2014

European Journal of Cardio-Thoracic Surgery

View full text Add to dashboard Cite

The robotic approach in thoracic surgery has rapidly gained popularity in recent years. As with the introduction of any new technology, this warrants not only adaptation of the operative technique itself, but also the evolution of appropriate troubleshooting strategies. A selected number of helpful tips and technical procedural manoeuvres have been compiled to prevent intraoperative problems, as well as to overcome challenging situations that can arise during robotic lobectomies. In robotic surgery, as opposed to open surgery or video-assisted thoracic surgery, these tips serve an important purpose for the operating surgeon, as well as the entire surgical team involved in the procedure. All the assembled recommendations have proved their effectiveness and have been successfully used by the authors in many procedures. Furthermore, these manoeuvres have been found to be of great importance in the training and proctoring of thoracic surgeons, fellows and residents (bed-side assistants). This guide of clearly arranged tips and troubleshooting strategies offers surgeons a useful tool to overcome difficult situations in robotic lobectomy and preferably improve the reproducibility and safety of their procedures.

show abstract

Minimally Invasive Resections for Lung Cancer

Blackmon

2014

Lung Cancer

View full text Add to dashboard Cite

Robotic lobectomy for non–small cell lung cancer (NSCLC): Long-term oncologic results

Abstract: Robotic lobectomy for early-stage NSCLC can be performed with low morbidity and mortality. Long-term stage-specific survival is acceptable and consistent with prior results for VATS and thoracotomy.

Cited by 256 publications

References 18 publications

Surgery for nonsmall cell lung cancer

Surgery for nonsmall cell lung cancer

Robotic lobectomy: tips, pitfalls and troubleshooting

Minimally Invasive Resections for Lung Cancer

Contact Info

Product

Resources

About